Invesco
CLOV icon

Invesco’s Clover Health Investments CLOV Stock Holding History

Invesco’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7M Buy
1,336,790
+308,419
+30% +$1.05M ﹤0.01% 2084
2026
Q1 		$1.81M Buy
1,028,371
+165,174
+19% +$358K ﹤0.01% 2589
2025
Q4 		$2.03M Sell
863,197
-94,760
-10% -$259K ﹤0.01% 2602
2025
Q3 		$2.93M Sell
957,957
-161,056
-14% -$460K ﹤0.01% 2467
2025
Q2 		$3.12M Sell
1,119,013
-55,192
-5% -$181K ﹤0.01% 2401
2025
Q1 		$4.22M Sell
1,174,205
-214,061
-15% -$860K ﹤0.01% 2237
2024
Q4 		$4.37M Sell
1,388,266
-8,374
-0.6% -$29.9K ﹤0.01% 2322
2024
Q3 		$3.94M Buy
1,396,640
+62,303
+5% +$143K ﹤0.01% 2354
2024
Q2 		$1.64M Buy
1,334,337
+4,197
+0.3% +$3.77K ﹤0.01% 2679
2024
Q1 		$1.06M Buy
1,330,140
+475,605
+56% +$433K ﹤0.01% 2963
2023
Q4 		$814K Buy
854,535
+9,384
+1% +$9.21K ﹤0.01% 2987
2023
Q3 		$913K Buy
845,151
+8,669
+1% +$10.3K ﹤0.01% 2906
2023
Q2 		$750K Sell
836,482
-148,612
-15% -$132K ﹤0.01% 3026
2023
Q1 		$833K Buy
985,094
+590,335
+150% +$646K ﹤0.01% 2988
2022
Q4 		$367K Sell
394,759
-16,311
-4% -$21.8K ﹤0.01% 3425
2022
Q3 		$699K Buy
411,070
+6,991
+2% +$18.3K ﹤0.01% 3070
2022
Q2 		$865K Buy
404,079
+173,492
+75% +$461K ﹤0.01% 3048
2022
Q1 		$819K Buy
230,587
+204,958
+800% +$594K ﹤0.01% 3158
2021
Q4 		$95K Buy
25,629
+15,019
+142% +$92.1K ﹤0.01% 3909
2021
Q3 		$78K Sell
10,610
-25
-0.2% -$214 ﹤0.01% 3967
2021
Q2 		$141K Buy
+10,635
New +$104K ﹤0.01% 3843
2021
Q1 		– Sell
-536,723
Closed -$9M – 3869
2020
Q4 		$9M Buy
+536,723
New +$5.98M ﹤0.01% 1868

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco's CLOV Position: Q2 2026 in Review

Invesco increased its Clover Health Investments (CLOV) stake by 30% in Q2 2026, buying an estimated $1.05M and bringing the position to 1,336,790 shares worth $7M. The position accounts for ﹤0.01% of the portfolio, ranked #2084.

Invesco first reported a position in CLOV in Q4 2020 and has held it in 22 quarters since. The position peaked at $9M in Q4 2020. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Invesco held 1,336,790 shares of Clover Health Investments worth $7M as of Q2 2026.
  • Invesco bought 308,419 Clover Health Investments shares in Q2 2026, an estimated $1.05M.
  • Clover Health Investments made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2084 holding.
  • Invesco first reported a position in Clover Health Investments in Q4 2020 and has held it in 22 quarters since.
  • Invesco's Clover Health Investments position peaked at $9M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.